World Bank’s “Investing in Health”: The cost of antimicrobial resistance is too high to ignore
Enis Baris, sector manager of the World Bank’s health, nutrition, and population practice in Europe and Central Asia, discusses findings from a new World Bank report on antimicrobial resistance and its costs, writing, “All we need is a political commitment at the highest level for an additional annual investment of $9 billion into human and animal health. … [I]t is imperative that we do invest and invest now. And only then that we all, health care providers and patients alike, could safeguard the very essence of health care with humanism and compassion” (9/21).